A potent CB1 and CB2 receptor agonist (Kis = 0.58-5 and 0.69-2.8 nM for human recombinant CB1 and CB2, respectively); considerably more potent than Δ9-THC in both behavioral tests and in receptor binding assays; suppresses locomotor activity, increases tail flick latency in a hot plate test for analgesia, and decreases body temperature in mice in a dose-dependent manner; reduces body weight loss and running wheel activity in a rat model of anorexia nervosa